Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-14
SponsorStanford University
About this trial
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Eligibility criteria
Qualifiers
Diagnosed with a mood and/or anxiety disorder
Have proficiency to participate in psychotherapy in English
Scheduled to begin therapy at one of the study sites
RCADS score > 65
Disqualifiers
None
Trial design
Treatments tested in this trial
- Teleo
- Standard Videoconferencing
Treatment groups
156 Participants
are divided into 2 treatment groupsLocations
2Ohana Center for Child and Adolescent Behavioral Health93940, MontereyCalifornia, United States
Stanford University94305, StanfordCalifornia, United States
Sponsors and collaborators
Stanford University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
MainSquare Co. (dba 'Teleo')
Collaborator
Source ClinicalTrials.gov